您好, 歡迎來到化工儀器網(wǎng)! 登錄| 免費(fèi)注冊(cè)| 產(chǎn)品展廳| 收藏商鋪|
英國NIBSC標(biāo)準(zhǔn)品WHO標(biāo)準(zhǔn)品是深圳遠(yuǎn)揚(yáng)化學(xué)技術(shù)有限公司的熱銷產(chǎn)品,主要應(yīng)用在哪些領(lǐng)域呢?
英國國家生物制品檢定所是WHO的一個(gè)標(biāo)準(zhǔn)品供應(yīng)中心實(shí)驗(yàn)室,它的核心工作是制備、保存和分發(fā)WHO用于檢測(cè)生物制品質(zhì)量的標(biāo)準(zhǔn)品。NIBSC制備的流感毒株和檢測(cè)抗原、抗血清標(biāo)準(zhǔn)品,保障了各廠家順利的研究和生產(chǎn)。NIBSC提供對(duì)投入英國市場(chǎng)的生物藥品的獨(dú)立測(cè)試,尤其是用于英國兒童免疫計(jì)劃的疫苗;它同時(shí)也是歐盟控制藥品進(jìn)入歐盟市場(chǎng)的藥品控制實(shí)驗(yàn)室(OMCL)。 如果出現(xiàn)不能滿足藥品存放要求或患者出現(xiàn)不良反應(yīng)等問題,NIBSC 也可對(duì)已投入歐盟市場(chǎng)的產(chǎn)品進(jìn)行檢驗(yàn)。
NIBSC 戰(zhàn)略目標(biāo):對(duì)有關(guān)生物產(chǎn)品的問題給出回復(fù)和建議;提供生物藥品方面的國家科技力量,維持滿足科學(xué)和藥物學(xué)領(lǐng)域新發(fā)展需求的靈活性、專業(yè)知識(shí)和設(shè)施;
作為化驗(yàn)方法(如量化生物學(xué)活性以及確定生物產(chǎn)品特征和進(jìn)行安全評(píng)估)方面的機(jī)構(gòu)運(yùn)營并得到認(rèn)同;
在歐洲生物產(chǎn)品的控制和標(biāo)準(zhǔn)化方面,繼續(xù)發(fā)揮科學(xué)基礎(chǔ)開發(fā)的中心作用;
在生物藥品法規(guī)的科學(xué)方面幫助社會(huì)達(dá)成共識(shí),并籍于此,與世界衛(wèi)生組織緊密合作;
在控制和標(biāo)準(zhǔn)化的關(guān)鍵領(lǐng)域?qū)崿F(xiàn)和維護(hù)質(zhì)量鑒定。
生物藥品控制
藥品中使用的生物物質(zhì)包括病毒和細(xì)菌疫苗、從人類血液提取的產(chǎn)物、荷爾蒙以及其它諸如細(xì)胞分裂素和生長素等治療藥物。
這些生物物質(zhì)對(duì)藥物學(xué)和公眾健康做出了巨大貢獻(xiàn)并發(fā)揮著越來越大的作用,它們大大改善了*的疾病預(yù)防、診斷和治療。
深圳遠(yuǎn)揚(yáng)化學(xué)技術(shù)有限公司所售英國NIBSC標(biāo)準(zhǔn)品部分產(chǎn)品列表:
(篇幅有限,更多產(chǎn)品,歡迎進(jìn)入我司展臺(tái)查詢)
07/288 | BCG Vaccine of Russian BCG-I sub-strain(15st WHO Reference Reagent) |
01/535 | Meningococcal serogroup W polysaccharide |
07/352 | BCG Vaccine of Russian BCG-I sub-strain(79st WHO Reference Reagent) |
07/281 | BCG Vaccine of Russian BCG-I sub-strain(8st WHO Reference Reagent) |
10/164 | Reteplase Reference Material |
95/571 | Interleukin-32 (Human, rDNA derived) |
13/219 | Influenza Antigen B/Massachusetts/02/2097 (Egg derived) |
10/149 | Reteplase Reference Material |
07/344 | BCG Vaccine of Russian BCG-I sub-strain(71st WHO Reference Reagent) |
01/484 | Meningococcal serogroup W polysaccharide |
13/154 | Influenza Antigen B/Massachusetts/02/2032 (Egg derived) |
13/151 | Influenza Antigen B/Massachusetts/02/2029 (Egg derived) |
10/143 | Reteplase Reference Material |
01/476 | Meningococcal serogroup W polysaccharide |
12/B623-057 | QCRFLUAH1N1QC1-Influenza AH1N1 QC55 |
12/B623-053 | QCRFLUAH1N1QC1-Influenza AH1N1 QC51 |
12/B623-051 | QCRFLUAH1N1QC1-Influenza AH1N1 QC49 |
13/275 | Polio Anti Sabin type 58 (inactivated) Serum |
12/B623-003 | QCRFLUAH1N1QC1-Influenza AH1N1 QC1 |
07/315 | BCG Vaccine of Russian BCG-I sub-strain(42st WHO Reference Reagent) |
13/285 | Polio Anti Sabin type 68 (inactivated) Serum |
03/104-019 | HTLV-4 (antibody) Monitor Sample |
13/153 | Influenza Antigen B/Massachusetts/02/2031 (Egg derived) |
12/B623-097 | QCRFLUAH1N1QC1-Influenza AH1N1 QC95 |
10/144 | Reteplase Reference Material |
95/657 | Interleukin-118 (Human, rDNA derived) |
13/219 | Polio Anti Sabin type 2 (inactivated) Serum |
03/104-085 | HTLV-70 (antibody) Monitor Sample |
01/472 | Meningococcal serogroup W polysaccharide |
13/146 | Influenza Antigen B/Massachusetts/02/2024 (Egg derived) |
07/329 | BCG Vaccine of Russian BCG-I sub-strain(56st WHO Reference Reagent) |
13/165 | Influenza Antigen B/Massachusetts/02/2043 (Egg derived) |
13/281 | Polio Anti Sabin type 64 (inactivated) Serum |
07/306 | BCG Vaccine of Russian BCG-I sub-strain(33st WHO Reference Reagent) |
03/104-110 | HTLV-95 (antibody) Monitor Sample |
07/358 | BCG Vaccine of Russian BCG-I sub-strain(85st WHO Reference Reagent) |
01/452 | Meningococcal serogroup W polysaccharide |
13/277 | Polio Anti Sabin type 60 (inactivated) Serum |
07/287 | BCG Vaccine of Russian BCG-I sub-strain(14st WHO Reference Reagent) |
13/287 | Polio Anti Sabin type 70 (inactivated) Serum |
13/307 | Polio Anti Sabin type 90 (inactivated) Serum |
10/186 | Reteplase Reference Material |
10/133 | Reteplase Reference Material |
03/104-094 | HTLV-79 (antibody) Monitor Sample |
12/B623-031 | QCRFLUAH1N1QC1-Influenza AH1N1 QC29 |
07/377 | BCG Vaccine of Russian BCG-I sub-strain(104st WHO Reference Reagent) |
13/269 | Polio Anti Sabin type 52 (inactivated) Serum |
10/179 | Reteplase Reference Material |
10/210 | Reteplase Reference Material |
13/266 | Polio Anti Sabin type 49 (inactivated) Serum |
07/295 | BCG Vaccine of Russian BCG-I sub-strain(22st WHO Reference Reagent) |
07/371 | BCG Vaccine of Russian BCG-I sub-strain(98st WHO Reference Reagent) |
12/B623-078 | QCRFLUAH1N1QC1-Influenza AH1N1 QC76 |
01/462 | Meningococcal serogroup W polysaccharide |
95/591 | Interleukin-52 (Human, rDNA derived) |
01/464 | Meningococcal serogroup W polysaccharide |
10/159 | Reteplase Reference Material |
03/104-046 | HTLV-31 (antibody) Monitor Sample |
13/213 | C-Peptide, Human. 68st International Standard. |
13/222 | Influenza Antigen B/Massachusetts/02/2100 (Egg derived) |
07/373 | BCG Vaccine of Russian BCG-I sub-strain(100st WHO Reference Reagent) |
12/B623-110 | QCRFLUAH1N1QC1-Influenza AH1N1 QC108 |
13/196 | C-Peptide, Human. 51st International Standard. |
12/B623-043 | QCRFLUAH1N1QC1-Influenza AH1N1 QC41 |
01/494 | Meningococcal serogroup W polysaccharide |
13/192 | Influenza Antigen B/Massachusetts/02/2070 (Egg derived) |
07/325 | BCG Vaccine of Russian BCG-I sub-strain(52st WHO Reference Reagent) |
07/348 | BCG Vaccine of Russian BCG-I sub-strain(75st WHO Reference Reagent) |
13/223 | Influenza Antigen B/Massachusetts/02/2101 (Egg derived) |
12/B623-086 | QCRFLUAH1N1QC1-Influenza AH1N1 QC84 |
13/191 | Influenza Antigen B/Massachusetts/02/2069 (Egg derived) |
01/488 | Meningococcal serogroup W polysaccharide |
07/343 | BCG Vaccine of Russian BCG-I sub-strain(70st WHO Reference Reagent) |
12/B623-019 | QCRFLUAH1N1QC1-Influenza AH1N1 QC17 |
10/125 | Reteplase Reference Material |
10/155 | Reteplase Reference Material |
13/185 | Influenza Antigen B/Massachusetts/02/2063 (Egg derived) |
13/243 | C-Peptide, Human. 98st International Standard. |
13/137 | Influenza Antigen B/Massachusetts/02/2015 (Egg derived) |
13/201 | C-Peptide, Human. 56st International Standard. |
07/311 | BCG Vaccine of Russian BCG-I sub-strain(38st WHO Reference Reagent) |
13/242 | C-Peptide, Human. 97st International Standard. |
13/175 | C-Peptide, Human. 30st International Standard. |
13/201 | Influenza Antigen B/Massachusetts/02/2079 (Egg derived) |
03/104-041 | HTLV-26 (antibody) Monitor Sample |
03/104-074 | HTLV-59 (antibody) Monitor Sample |
95/646 | Interleukin-107 (Human, rDNA derived) |
13/156 | C-Peptide, Human. 11st International Standard. |
01/465 | Meningococcal serogroup W polysaccharide |
03/104-050 | HTLV-35 (antibody) Monitor Sample |
10/121 | Reteplase Reference Material |
13/235 | Influenza Antigen B/Massachusetts/02/2113 (Egg derived) |
01/519 | Meningococcal serogroup W polysaccharide |
07/364 | BCG Vaccine of Russian BCG-I sub-strain(91st WHO Reference Reagent) |
95/566 | Interleukin-27 (Human, rDNA derived) |
13/204 | C-Peptide, Human. 59st International Standard. |
13/205 | Influenza Antigen B/Massachusetts/02/2083 (Egg derived) |
13/241 | C-Peptide, Human. 96st International Standard. |
07/324 | BCG Vaccine of Russian BCG-I sub-strain(51st WHO Reference Reagent) |
95/626 | Interleukin-87 (Human, rDNA derived) |
請(qǐng)輸入賬號(hào)
請(qǐng)輸入密碼
請(qǐng)輸驗(yàn)證碼
以上信息由企業(yè)自行提供,信息內(nèi)容的真實(shí)性、準(zhǔn)確性和合法性由相關(guān)企業(yè)負(fù)責(zé),化工儀器網(wǎng)對(duì)此不承擔(dān)任何保證責(zé)任。
溫馨提示:為規(guī)避購買風(fēng)險(xiǎn),建議您在購買產(chǎn)品前務(wù)必確認(rèn)供應(yīng)商資質(zhì)及產(chǎn)品質(zhì)量。